Novartis takes aim at Shire and Allergan with dry-eye drugSwiss company takes option on Lubris’ ECF843. Share XNovartis takes aim at Shire and Allergan with dry-eye drughttps://pharmaphorum.com/news/novartis-takes-aim-shire-allergan-dry-eye-drug/
Shire launches potential blockbuster dry eye drug in USXiidra could be ophthalmology blockbuster. Share XShire launches potential blockbuster dry eye drug in UShttps://pharmaphorum.com/news/shire-launches-dry-eye-drug-us/